Physical Activity, by Enhancing Parasympathetic Tone and Activating the Cholinergic Anti-inflammatory Pathway, is a Therapeutic Strategy to Restrain Chronic Inflammation and Prevent Many Chronic Diseases
Overview
Authors
Affiliations
Chronic diseases are the leading cause of death in the world and chronic inflammation is a key contributor to many chronic diseases. Accordingly, interventions that reduce inflammation may be effective in treating multiple adverse chronic conditions. In this context, physical activity is documented to reduce systemic low-grade inflammation and is acknowledged as an anti-inflammatory intervention. Furthermore, physically active individuals are at a lower risk of developing chronic diseases. However the mechanisms mediating this anti-inflammatory phenotype and range of health benefits are unknown. We hypothesize that the "cholinergic anti-inflammatory pathway" (CAP) mediates the anti-inflammatory phenotype and range of health benefits associated with physical activity. The CAP is an endogenous, physiological mechanism by which acetylcholine from the vagus nerve, interacts with the innate immune system to modulate and restrain the inflammatory cascade. Importantly, higher levels of physical activity are associated with enhanced parasympathetic (vagal) tone and lower levels of C-reactive protein, a marker of low-grade inflammation. Accordingly, physical activity, by enhancing parasympathetic tone and activating the CAP, may be a therapeutic strategy to restrain chronic inflammation and prevent many chronic diseases.
Tam L, Hocker K, David T, Williams E Int J Environ Res Public Health. 2024; 21(5).
PMID: 38791769 PMC: 11121718. DOI: 10.3390/ijerph21050554.
Pate B, Smiley C, Harrington E, Bielicki B, Davis J, Reagan L Auton Neurosci. 2024; 253:103175.
PMID: 38677130 PMC: 11173375. DOI: 10.1016/j.autneu.2024.103175.
Seiler A, Milliken A, Leiter R, Blum D, Slavich G Compr Psychoneuroendocrinol. 2024; 17:100226.
PMID: 38482488 PMC: 10935511. DOI: 10.1016/j.cpnec.2024.100226.
Molani-Gol R, Rafraf M Eur J Nutr. 2024; 63(4):1023-1040.
PMID: 38374352 DOI: 10.1007/s00394-024-03335-9.
Dutra A, Salm D, Hardt da Silva R, Tanaka F, Lutdke D, Oliveira B Front Integr Neurosci. 2023; 17:1242278.
PMID: 37901799 PMC: 10602751. DOI: 10.3389/fnint.2023.1242278.